TY - JOUR
T1 - APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease
AU - Bruggeman, Leslie A.
AU - Wu, Zhenzhen
AU - Luo, Liping
AU - Madhavan, Sethu M.
AU - Konieczkowski, Martha
AU - Drawz, Paul E.
AU - Thomas, David B.
AU - Barisoni, Laura
AU - Sedor, John R.
AU - O'Toole, John F.
N1 - Publisher Copyright:
Copyright © 2016 by the American Society of Nephrology.
PY - 2016/12
Y1 - 2016/12
N2 - APOL1 risk variants are associatedwith kidney disease in blacks, but themechanisms of renal injury associated with APOL1 risk variants are unknown. Because APOL1 is unique to humans and some primates, we created transgenic (Tg) mice using the promoter of nephrin-encoding Nphs1 to express the APOL1 reference sequence (G0) or the G2 risk variant in podocytes, establishing Tg lines with a spectrum of APOL1 expression levels. Podocytes fromTg-G0 and Tg-G2mice did not undergo necrosis, apoptosis, or autophagic cell death in vivo, even in lines with highly expressed transgenes. Further, Tg-G0 and Tg-G2 mice did not develop kidney pathology, proteinuria, or azotemia as of 300 days of age. However, by 200 days of age, Tg-G2 mice had significantly lower podocyte density than age-matched WT and Tg-G0 mice had, a difference that was not evident at weaning. Notably, a pregnancy-associated phenotype that encompassed eclampsia, preeclampsia, fetal/neonatal deaths, and small litter sizes occurred in some Tg-G0 mice and more severely in Tg-G2 mice. Similar to human placenta, placentas of Tg mice expressed APOL1. Overall, these results suggest podocyte depletion could predispose individuals with APOL1 risk genotypes to kidney disease in response to a second stressor, and add to other published evidence associating APOL1 expression with preeclampsia.
AB - APOL1 risk variants are associatedwith kidney disease in blacks, but themechanisms of renal injury associated with APOL1 risk variants are unknown. Because APOL1 is unique to humans and some primates, we created transgenic (Tg) mice using the promoter of nephrin-encoding Nphs1 to express the APOL1 reference sequence (G0) or the G2 risk variant in podocytes, establishing Tg lines with a spectrum of APOL1 expression levels. Podocytes fromTg-G0 and Tg-G2mice did not undergo necrosis, apoptosis, or autophagic cell death in vivo, even in lines with highly expressed transgenes. Further, Tg-G0 and Tg-G2 mice did not develop kidney pathology, proteinuria, or azotemia as of 300 days of age. However, by 200 days of age, Tg-G2 mice had significantly lower podocyte density than age-matched WT and Tg-G0 mice had, a difference that was not evident at weaning. Notably, a pregnancy-associated phenotype that encompassed eclampsia, preeclampsia, fetal/neonatal deaths, and small litter sizes occurred in some Tg-G0 mice and more severely in Tg-G2 mice. Similar to human placenta, placentas of Tg mice expressed APOL1. Overall, these results suggest podocyte depletion could predispose individuals with APOL1 risk genotypes to kidney disease in response to a second stressor, and add to other published evidence associating APOL1 expression with preeclampsia.
UR - http://www.scopus.com/inward/record.url?scp=85017205189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85017205189&partnerID=8YFLogxK
U2 - 10.1681/ASN.2015111220
DO - 10.1681/ASN.2015111220
M3 - Article
C2 - 27026370
AN - SCOPUS:85017205189
SN - 1046-6673
VL - 27
SP - 3600
EP - 3610
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 12
ER -